Article Text
Letters
Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis
Statistics from Altmetric.com
Footnotes
-
Competing interests IM and HW received research funding and honoraria from Abbott, Roche and Schering-Plough, TW and DMO from Abbott, Bristol-Myers Squibb, Roche, UCB and Wyeth/Pfizer.
-
Provenance and peer review Not commissioned; externally peer reviewed.